Certificate number:RU.77.99.11.003.Е.003029.07.16
Date of registration and renewal:18.07.2016
Dosage form: & nbspCapsules weighing 450 mg
Classification "Composition" & nbsp BADs - fats, fatty substances and their derivatives
Classification "Clinical" & nbsp BAA sources of fatty acids
Composition: & nbspFish oil, Е306, Е339ii, Е407, Е422, Е1440.
Scope: & nbspFor realization to the population as biologically active additive to food - an additional source of polyunsaturated fatty acids omega-3
Suggested Usage: & nbspAdults take 2 capsules daily with meals. Duration of admission - 1 month, if necessary, reception can be repeated.
Contraindications:Individual intolerance of components. Before use, it is recommended to consult a doctor.
Shelf life:2 years.
Storage conditions:Store in the original packaging in a dry place, protected from light and out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:Instead of witnessing the state registration No. RU.77.99.11.003.Е.010285.11.13 of 29.11.2013, the expert opinion of the FGBU Research Institute for Nutrition of RAMS №72 / E-1054 / б-13 of 31.10.2013, FGBUN "FIC nutrition and biotechnology № 529 / Э-487 / б-16 of 06/09/2016.
Recipient:Pfizer Innovations, LLCPfizer Innovations, LLC Russian Federation
Information update date: & nbsp20.11.2016
Instructions
Up